| Dr Navkaran B Singh, MD | |
|
9280 W Sunset Rd Ste 400, Las Vegas, NV 89148-4862 | |
| (702) 366-1268 | |
| (702) 366-7079 |
| Full Name | Dr Navkaran B Singh |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 35 Years |
| Location | 9280 W Sunset Rd Ste 400, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033112925 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 17275 (Nevada) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Women's Health Associates Of Southern Nevada- Martin, Pllc | 4082845664 | 82 |
News Archive
Fifteen first responders received payments from a federal fund set up to compensate people who were sickened by the Sept. 11 terrorist attacks. So far, fewer applications have been received by the fund than officials estimated they would receive.
A new research discovery has the potential to revolutionize the biological understanding of some childhood psychiatric disorders. Specifically, scientists have found that when a single protein involved in brain development, called "SRGAP3," is malformed, it causes problems in the brain functioning of mice that cause symptoms that are similar to some mental health and neurological disorders in children.
SIRO Clinpharm, a Contract Research Organization (CRO) with a presence in India, Western and Central Eastern Europe, and the United States today announced its alliance with DreamCIS Inc., a leading CRO based in Seoul, South Korea.
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.
› Verified 5 days ago
| Entity Name | Iriye Medical Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467496240 PECOS PAC ID: 2163415910 Enrollment ID: O20040406001830 |
News Archive
Fifteen first responders received payments from a federal fund set up to compensate people who were sickened by the Sept. 11 terrorist attacks. So far, fewer applications have been received by the fund than officials estimated they would receive.
A new research discovery has the potential to revolutionize the biological understanding of some childhood psychiatric disorders. Specifically, scientists have found that when a single protein involved in brain development, called "SRGAP3," is malformed, it causes problems in the brain functioning of mice that cause symptoms that are similar to some mental health and neurological disorders in children.
SIRO Clinpharm, a Contract Research Organization (CRO) with a presence in India, Western and Central Eastern Europe, and the United States today announced its alliance with DreamCIS Inc., a leading CRO based in Seoul, South Korea.
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.
› Verified 5 days ago
| Entity Name | Women's Health Associates Of Southern Nevada- Martin, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598906166 PECOS PAC ID: 4082845664 Enrollment ID: O20140324002121 |
News Archive
Fifteen first responders received payments from a federal fund set up to compensate people who were sickened by the Sept. 11 terrorist attacks. So far, fewer applications have been received by the fund than officials estimated they would receive.
A new research discovery has the potential to revolutionize the biological understanding of some childhood psychiatric disorders. Specifically, scientists have found that when a single protein involved in brain development, called "SRGAP3," is malformed, it causes problems in the brain functioning of mice that cause symptoms that are similar to some mental health and neurological disorders in children.
SIRO Clinpharm, a Contract Research Organization (CRO) with a presence in India, Western and Central Eastern Europe, and the United States today announced its alliance with DreamCIS Inc., a leading CRO based in Seoul, South Korea.
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Navkaran B Singh, MD 8906 Spanish Ridge Ave Ste 202, Las Vegas, NV 89148-1319 Ph: (702) 330-3102 | Dr Navkaran B Singh, MD 9280 W Sunset Rd Ste 400, Las Vegas, NV 89148-4862 Ph: (702) 366-1268 |
News Archive
Fifteen first responders received payments from a federal fund set up to compensate people who were sickened by the Sept. 11 terrorist attacks. So far, fewer applications have been received by the fund than officials estimated they would receive.
A new research discovery has the potential to revolutionize the biological understanding of some childhood psychiatric disorders. Specifically, scientists have found that when a single protein involved in brain development, called "SRGAP3," is malformed, it causes problems in the brain functioning of mice that cause symptoms that are similar to some mental health and neurological disorders in children.
SIRO Clinpharm, a Contract Research Organization (CRO) with a presence in India, Western and Central Eastern Europe, and the United States today announced its alliance with DreamCIS Inc., a leading CRO based in Seoul, South Korea.
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.
› Verified 5 days ago
Dr. Geoffrey Hsieh, M.D Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 700 Shadow Ln Ste 370, Las Vegas, NV 89106 Phone: 702-693-6870 Fax: 702-693-6899 | |
Jeffrey Ta Liu, MD - LLC Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3040 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-477-0707 Fax: 888-232-5937 | |
Leslie L Zak, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2851 N Tenaya Way, Suite 208, Las Vegas, NV 89128 Phone: 702-228-0319 Fax: 702-477-0254 | |
Jennifer Wong, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2880 N Tenaya Way Ste 420, Las Vegas, NV 89128 Phone: 702-255-2022 Fax: 702-255-8810 | |
Dr. Jessica B Colwill, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 8906 Spanish Ridge Ave Ste 202, Las Vegas, NV 89148 Phone: 702-577-1622 Fax: 702-912-4994 | |
Dr. Staci Leigh Mchale, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 8850 W Sunset Rd, Suite #110, Las Vegas, NV 89148 Phone: 702-740-0500 Fax: 702-740-0502 |